Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,283,000 | 217,000 | 240,000 | 215,000 | 261,000 |
| Marketable Securities | 2,309,000 | 1,749,000 | 1,645,000 | 1,447,000 | 1,001,000 |
| Inventories | 2,277,000 | 1,537,000 | 1,154,000 | 855,000 | 804,000 |
| Other current assets | 5,201,000 | 2,490,000 | 2,389,000 | 2,206,000 | 2,223,000 |
| TOTAL | $11,268,000 | $6,080,000 | $5,509,000 | $4,802,000 | $4,368,000 |
| Non-Current Assets | |||||
| PPE Net | 6,642,000 | 3,720,000 | 3,633,000 | 3,583,000 | 3,853,000 |
| Intangibles | 1,136,000 | 144,000 | 106,000 | N/A | N/A |
| Other Non-Current Assets | 2,544,000 | 483,000 | 98,000 | 52,000 | 93,000 |
| TOTAL | $10,322,000 | $4,347,000 | $3,837,000 | $3,635,000 | $3,946,000 |
| Total Assets | $21,590,000 | $10,427,000 | $9,346,000 | $8,437,000 | $8,314,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,281,000 | 2,250,000 | 1,317,000 | 1,181,000 | 1,546,000 |
| Accounts payable and accrued liabilities | 812,000 | 367,000 | 293,000 | 299,000 | 270,000 |
| TOTAL | $9,084,000 | $5,263,000 | $4,145,000 | $3,886,000 | $4,154,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,751,000 | 1,260,000 | 1,804,000 | 1,841,000 | 1,699,000 |
| Other Non-Current Liabilities | 556,000 | 660,000 | 563,000 | 773,000 | 1,152,000 |
| TOTAL | $3,551,000 | $1,971,000 | $2,433,000 | $2,661,000 | $2,893,000 |
| Total Liabilities | $12,635,000 | $7,234,000 | $6,578,000 | $6,547,000 | $7,047,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,556,000 | 910,000 | 906,000 | 894,000 | 886,000 |
| Retained earnings | 4,276,000 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 1,849,000 | 983,000 | 647,000 | 144,000 | -282,000 |
| TOTAL | $7,711,000 | $3,142,000 | $2,702,000 | $1,843,000 | $1,225,000 |
| Total Liabilities And Equity | $20,346,000 | $10,376,000 | $9,280,000 | $8,390,000 | $8,272,000 |